Aligos Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US01626L1052
  • NASDAQ: ALGS
USD
5.56
-0.12 (-2.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAligos Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-2.11%
-0.75%
1W
10.1%
2.04%
1M
-16.64%
0.41%
YTD
-40.34%
12.57%
1Y
-45.76%
15.76%
3Y
630.62%
78.38%
5Y
-98.6%
73.21%
10Y
%
255.99%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.59%
0%
-1.59%
6 Months
-19.07%
0%
-19.07%
1 Year
-45.76%
0%
-45.76%
2 Years
-31.36%
0%
-31.36%
3 Years
630.62%
0%
630.62%
4 Years
424.53%
0%
424.53%
5 Years
-98.6%
0%
-98.6%

Aligos Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading